DK1713476T3 - Et nyt medicinindgiftssystem til protonnpumpehæmmere og proces dertil - Google Patents

Et nyt medicinindgiftssystem til protonnpumpehæmmere og proces dertil

Info

Publication number
DK1713476T3
DK1713476T3 DK04820975.3T DK04820975T DK1713476T3 DK 1713476 T3 DK1713476 T3 DK 1713476T3 DK 04820975 T DK04820975 T DK 04820975T DK 1713476 T3 DK1713476 T3 DK 1713476T3
Authority
DK
Denmark
Prior art keywords
delivery system
drug delivery
proton pump
pump inhibitors
new drug
Prior art date
Application number
DK04820975.3T
Other languages
English (en)
Inventor
Mannalal Ramgopal Bajaj
Rajan Shantaram Samant
Bharat Babulal Shah
Original Assignee
Lyka Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34746668&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1713476(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lyka Labs Ltd filed Critical Lyka Labs Ltd
Application granted granted Critical
Publication of DK1713476T3 publication Critical patent/DK1713476T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
DK04820975.3T 2003-11-05 2004-11-03 Et nyt medicinindgiftssystem til protonnpumpehæmmere og proces dertil DK1713476T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1164MU2003 2003-11-05
PCT/IN2004/000342 WO2005065682A2 (en) 2003-11-05 2004-11-03 Rabeprazole containing formulation

Publications (1)

Publication Number Publication Date
DK1713476T3 true DK1713476T3 (da) 2010-08-09

Family

ID=34746668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04820975.3T DK1713476T3 (da) 2003-11-05 2004-11-03 Et nyt medicinindgiftssystem til protonnpumpehæmmere og proces dertil

Country Status (11)

Country Link
US (1) US20070014875A1 (da)
EP (1) EP1713476B1 (da)
AT (1) ATE466579T1 (da)
BR (1) BRPI0416027A (da)
CY (1) CY1110717T1 (da)
DE (1) DE602004027088D1 (da)
DK (1) DK1713476T3 (da)
ES (1) ES2344905T3 (da)
PL (1) PL1713476T3 (da)
PT (1) PT1713476E (da)
WO (1) WO2005065682A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0711048A2 (pt) * 2006-05-09 2011-08-23 Astrazeneca Ab formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável
CN102138907A (zh) * 2010-02-02 2011-08-03 南京长澳医药科技有限公司 一种稳定的雷贝拉唑钠冻干制剂及其制备方法
CN103463636B (zh) * 2013-09-17 2015-05-27 天津市嵩锐医药科技有限公司 一种供注射用的泮托拉唑钠药物组合物
MA41623A (fr) * 2015-11-26 2018-01-09 Verano Ilac Sanayi Ve Ticaret A S Composition lyophilisée de composé de benzimidazole

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0651727T3 (da) * 1992-07-20 1997-10-13 Unilever Plc Fremstilling af gashydrater.
ES2093445T3 (es) * 1992-07-28 1996-12-16 Astra Ab Inyeccion y estuche de inyeccion que contiene omeprazol y sus analogos.
TW280770B (da) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
US7396841B2 (en) * 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections

Also Published As

Publication number Publication date
BRPI0416027A (pt) 2007-01-02
US20070014875A1 (en) 2007-01-18
ATE466579T1 (de) 2010-05-15
EP1713476B1 (en) 2010-05-05
PT1713476E (pt) 2010-08-04
DE602004027088D1 (de) 2010-06-17
WO2005065682A3 (en) 2005-09-01
ES2344905T3 (es) 2010-09-09
CY1110717T1 (el) 2015-06-10
EP1713476A2 (en) 2006-10-25
PL1713476T3 (pl) 2010-10-29
WO2005065682A2 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
CY1121877T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει πιμοβενδανη
PH12021550302A1 (en) Methods for the administration of certain vmat2 inhibitors
RS52831B (en) THIN BUPRENORPHINE TILES FOR DRUG REPLACEMENT THERAPY
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
EA201300465A1 (ru) Устойчивые оральные фармацевтические дозированные формы, содержащие опиоидный анальгетик
IS8230A (is) Setið 2-amínótetralín til notkunar við meðferð á þunglyndi
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
ZA200501116B (en) Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
EA200801619A1 (ru) Способ улучшения фармакокинетики ингибиторов интегразы вич (варианты), набор и фармацевтическая композиция (варианты)
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
AR059357A1 (es) Formulaciones farmaceuticas
NO20055207L (no) Oralt farmasoytisk preparat for protonpumpeantagonister
CY1110717T1 (el) Ενα πρωτοτυπο συστημα χορηγησης φαρμακου για τους αναστολεις αντλιας πρωτονιων και τις διαδικασιες τους
AR057885A1 (es) Acido 1-(1-(2- etoxietil) - 1- etil-7-(4- metilpiridin -2- ilamino)- 1h pirazolo (4,3-d) pirimidin -5- il) piperidina -4- carboxilico y las sales del mismo. composiciones farmaceuticas.
CY1111919T1 (el) Ηλεκτρικο αλας της 2-((4-(1-μεθυλ-4-(πυριδιν-4-υλ)-1η-πυραζολ-3-υλ)-φαινοξυ)μεθυλ)κινολινης
GEP20125526B (en) Drug active in neuropathic pain
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
EA200501164A1 (ru) Индазоламиды с аналгетической активностью
TW200502232A (en) Process for preparing isomerically pure prodrugs of proton pump inhibitors
DE602007004348D1 (de) Arzneimittel zur behandlung von sarkoglykanopathien
EA201070194A1 (ru) Стабильная жидкая фармацевтическая композиция на основе тразодона
PH12020500436A1 (en) Aromatic derivative, preparation method for same, and medical applications thereof
UY30412A1 (es) Derivados de las 1-([1h-benzimidazol-5il]carbonil)-piperidin-carboxamidas n-sustituidas, composiciones farmacéuticas conteniéndolos, proceso de preparacion y aplicaciones
DE50312458D1 (de) Iminosäurederivate als inhibitoren von matrix-metalloproteinasen